BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 

Wednesday, April 23, 2014
 
QRxPharma Pty Ltd. Fails To Win Panel Backing For New Painkiller Moxduo    More...

Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal    More...

Billionaire Ackman, Valeant Pharmaceuticals International (VRX) Team Up To Make $45.6 Billion Allergan Inc. (AGN) Bid    More...

FDA Approves Eli Lilly and Company (LLY)'s Cyramza For Stomach Cancer    More...

Pfizer Inc. (PFE) Shows Off Top Data For Two Phase 3 Psoriasis Trials    More...

Bay Area's Principia Biopharma Secures $50 Million Series B Financing    More...

ProNAi Therapeutics, Inc. Banks $59.5 Million Series D To Fund Non-Hodgkin's Lymphoma Studies    More...

Menlo Park's Avalanche Biotechnologies Secures $55 Million    More...

 
More Breaking News



 
Pfizer Inc. (PFE) Cautiously Approaches Strained AstraZeneca PLC (AZN) With $101 Billion Buyout Deal    More...

AbbVie (ABBV) Moving Up To 2,000 Workers Off Abbott Laboratories (ABT) Campus    More...

U.S. In Danger Of Losing 140,000 Jobs If Status Quo Maintains, PhRMA Reports    More...

Massachusett's Zafgen Lines Up $86 Million IPO To Bankroll Obesity Drug Push    More...

Sarepta Therapeutics (SRPT) Erupts On Optimism Over Muscular Dystrophy Drug; Stock Up +39.26% At Market Close (April 21, 2014)    More...

Why People Love Working For Big Pharmas Like Biogen Idec, Inc. (Massachusetts) (BIIB), Celgene (CELG), And Gilead Sciences, Inc. (GILD)    More...

Aastrom Biosciences, Inc. (ASTM) Bags Sanofi (France) (SAN.PA)'s Cell Therapy And Regenerative Medicine Business For $6.5 Million Cash    More...

Ex-Sanofi (France) (SAN.PA) Executive Gets 16 Months For Insider Trading    More...

Could A Chocolate A Day Help Keep The Doctor Away? Heinrich Heine University Study    More...

God Can Help You With Romantic Rejection Woes, Stanford Graduate School Of Business Study    More...

 
More News

Did Chimerix, Inc. Set A Bad Example For Biopharma? </b>Did Chimerix, Inc. Set A Bad Example For Biopharma?

Chimerix generated some pretty negative publicity when it denied a dying seven-year old boy access to its experimental drug brincidofovir. Josh Hardy had developed an adenovirus infection following a bone marrow transplant related to past cancer treatment. Since Chimerix has a drug that has demonstrated some efficacy (albeit much of it anecdotal) in exactly this indication, doctors recommended the parents see about getting the medicine on a "compassionate use" basis. The company, however, demurred. More...
Executive Jobs
DepomedChief Medical Officer
CelgeneVice President, Global Medical Affairs
Novartis Institutes for BioMedical ResearchGlobal HR Partner, Executive Director
HospiraMedical Director, Biologics Medical Affairs

Search Jobs


Miles
Km80.5


 
Potential Impact On R&D If Pfizer Inc. (PFE) Succeeds In Taking Over AstraZeneca PLC (AZN)    More...
What Sarepta Therapeutics (SRPT)’ Next Move Should Be    More...
Novel Function Of Protein Linked To Alzheimer's Disease Uncovered, NNI Reveals    More...
Sleep Disorder Linked To Brain Diseases Such As Alzheimer's And Parkinson's, University of Toronto Study    More...
Your Menstrual Cycle Exposed: 6 Things Your Period Can Tell You About Your Health    More...
Ginseng Can Treat And Prevent Influenza, Georgia State University Study    More...
Alcoholism Makes Muscles Weaker, Thomas Jefferson University Study    More...
7 Things To Take Away From "What’s Hot in Boston Biotech"    More...
 
More Featured News


 

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.


Show me jobs for this employer
 
Feature Employer
 
Emerging Job Search Trends In 2014    More...

Hiring Managers Reveal The 15 BEST Words To Use On Your Resume    More...

10 Interview Questions; The Good, Bad, And The Ugly    More...

What Your Body Language Is Saying During The Interview    More...

The 2 Stages Of Job Search Rejection    More...

5 Resume Errors That Will Land You In The Trash    More...

5 Rules Of Employment Follow-Up    More...

3 Executive Resume Bloopers You’re Making Right Now    More...

3 Secrets To Interview-Winning Cover Letters    More...

6 Ways To Handle Irritating Colleagues    More...

 
More Career Tips



//-->